Flatley JAY T
SEC-identified person · CIK 1189130 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Rivian Automotive, Inc. / DE RIVN | Director | filed 2021 - 2026 |
| Denali Therapeutics Inc. DNLI | Director | filed 2017 - 2026 |
| Zymergen Inc. ZY | Director · Chairman and Acting CEO | filed 2021 - 2022 |
| Coherent INC COHR | Director | filed 2011 - 2022 |
| Senti Biosciences, Inc.\ SNTI | Director | filed 2021 - 2021 |
| Illumina, INC. ilmn#456 | Director · President and CEO | filed 2006 - 2021 |
| Juno Therapeutics, Inc. JUNO | Director | filed 2017 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.